Gut Microbiota and Sepsis-associated Acute Kidney Injury
GMASAKI
The Relationship Between Gut Microbiota and Sepsis-associated Acute Kidney Injury in Sepsis Patients:Multicenter Observational Study
1 other identifier
observational
60
1 country
1
Brief Summary
Sepsis has emerged as one of the important life-threatening infectious diseases with high morbidity and mortality. Sepsis-associated kidney injury (SAKI) is one of the most common and serious complications of sepsis. It has been found that intestinal flora may affect the occurrence and development of a variety of diseases, and may also affect the pathogenesis of multiple SAKI, which is also regulated by host genetic factors. Therefore, the investigators speculate that gut microbiota composition may be associated with susceptibility to SAKI, and there are no studies reporting the association between gut microbiota and SAKI. The investigators intend to carry out a multicenter study in conjunction with the Department of Intensive Care of Qinghai Provincial People's Hospital. The structure and function of intestinal flora in septic patients with renal injury and septic patients less susceptible to renal injury are studied by 16S rDNA amplicon sequencing technology. The differences in composition, diversity and structural stability of intestinal flora between the two groups are analyzed to explore the genera that play a key role in the occurrence of the disease. By analyzing the differences between renal injury and inflammation levels in each group, the correlation between intestinal flora and SAKI, the possible influencing links involved, and the related factors affecting the prognosis of SAKI were revealed. The results of this study are helpful to further elucidate the pathogenesis of SAKI and provide new ideas and methods for the prevention and treatment of SAKI.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Feb 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 10, 2023
CompletedStudy Start
First participant enrolled
February 1, 2023
CompletedFirst Posted
Study publicly available on registry
February 8, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedFebruary 8, 2023
January 1, 2023
1.9 years
January 10, 2023
January 30, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Differences in gut microbiota composition between the two groups
The differences in the composition of intestinal flora between the two groups were analyzed to identify the correlation with AKI
Within 24 hours of patient enrollment
Secondary Outcomes (1)
IL-6
Within 24 hours of patient enrollment
Study Arms (2)
Sepsis-associated kidney injury
Sepsis patients and acute kidney injury No intervention
Sepsis but no renal impairment
Sepsis patients without acute kidney injury
Interventions
Whether renal injury occurred and differences in intestinal flora
Eligibility Criteria
Sepsis patients who met the inclusion criteria were admitted to the First Affiliated Hospital of Xi'an Jiaotong University and Qinghai Provincial People 's Hospital during the study period.
You may qualify if:
- Age≥18 years;Meet the sepsis definition and diagnostic criteria of Sepsis-3.0 guidelines;No previous history of hypertension or diabetes; No underlying kidney disease such as nephrotic syndrome, no history of rheumatic immune system disease; Normal renal function before onset.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
First affliated hospital of Xi'an Jiaotong University
Xi'an, Shaanxi, 710061, China
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- OTHER
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
January 10, 2023
First Posted
February 8, 2023
Study Start
February 1, 2023
Primary Completion
December 31, 2024
Study Completion
December 31, 2024
Last Updated
February 8, 2023
Record last verified: 2023-01
Data Sharing
- IPD Sharing
- Will not share